Intravesical Gemcitabine and Docetaxel for BCG naïve Non-muscle Invasive Bladder Cancer

NCT04386746 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Urothelial Carcinoma Bladder
Bladder Cancer

Interventions

DRUG: Gemcitabine
DRUG: Docetaxel

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins